Plasma Therapy Not Approved As COVID-19 Treatment, Use Only For Trial: ICMR

Supported by

The Union Health Ministry, on Tuesday, warned that plasma therapy is not an approved method for treating the coronavirus and should be used for research and trial purposes.

Stressing on the fact that since convalescent plasma therapy does not have sufficient proof to substantiate its effectiveness, the Joint Secretary to the Union Health Ministry, Lav Agarwal, said that such treatments can be life-threatening if proper procedures are not followed.

‘The Indian Council of Medical Research (ICMR) has already stated very clearly that currently there are no approved therapies for COVID-19, including plasma therapies. Plasma therapies are being experimented with; however, there is no evidence to support that it can be used in treatment yet,’ said Agarwal.

The nodal body overseeing the coronavirus situation in the country has launched a national study to understand the effectiveness of plasma therapy as a treatment for COVID-19.

Agarwal also mentioned that unless robust proof is available, it should be considered only for research or for trial purposes.

‘Plasma therapy can have serious life-threatening complications if proper procedure and guidelines are not followed,’ he added. ‘Any treatment done without the ICMR’s approval is illegal,’ he added.

The statement comes at a time when the therapy is being considered as a potential treatment against the deadly virus and hospitals across several states have started applying for permission to the ICMR to start plasma therapy.

Convalescent plasma therapy involves injecting patients with plasma from people who have recovered. The antibodies in the plasma of a recovered patient aids in recovering a sick person.

According to the standards, a trial is conducted to test if a particular drug or therapy is safe and effective. If the result is positive, the drugs and therapies are then sent to drug regulatory bodies for approval, after which they become part of standard treatments.

On April 14, Delhi’s Max Healthcare’s Saket hospital had used plasma therapy on a Covid-19 patient making it the first instance in the country. The hospital administered plasma to a critically ill Covid-19 patient, who was on a ventilator. It sought and received approval on compassionate grounds.

Several states including Rajasthan, Gujarat and Karnataka have also sought permission from ICMR to treat critically-ill COVID-19 patients with this therapy.

Also Read: ‘India Should Be Placed On Religious Freedom Blacklist’: US Panel

#PoweredByYou We bring you news and stories that are worth your attention! Stories that are relevant, reliable, contextual and unbiased. If you read us, watch us, and like what we do, then show us some love! Good journalism is expensive to produce and we have come this far only with your support. Keep encouraging independent media organisations and independent journalists. We always want to remain answerable to you and not to anyone else.

Leave a Reply

Your email address will not be published. Required fields are marked *

Featured

Amplified by

P&G Shiksha

P&G Shiksha Turns 20 And These Stories Say It All

Amplified by

Isha Foundation

Sadhguru’s Meditation App ‘Miracle of Mind’ Hits 1 Million Downloads in 15 Hours, Surpassing ChatGPT’s Early Growth

Recent Stories

Dramatic Near-Crash in Indonesia: Batik Air 737 Battles Severe Crosswind, Pilot’s Quick Action Averts Disaster in Jakarta

India’s Human Trafficking Crisis: Meet 3 Real-Life Heroes Leading the Fight to Protect Women and Children

Over 6.2 Lakhs Cars Fined Wrongly On Mumbai-Pune Expressway Due To Camera Glitch, RTI Reveals

Contributors

Writer : 
Editor : 
Creatives :